|
Quotes & Info
|
| CI > SEC Filings for CI > Form 8-K on 26-May-2009 | All Recent SEC Filings |
26-May-2009
Regulation FD Disclosure
Beginning on May 26, 2009 and continuing through May 28, 2009, Company officials
expect to participate in telephone calls and meetings with investors and
analysts. During these meetings, Company officials expect to reaffirm
consolidated adjusted income from operations estimates for full year 2009, which
remain in the range of $1.02 billion to $1.08 billion, excluding any future
impact of the Guaranteed Minimum Death Benefits book of business also known as
Variable Annuity Death Benefits (VADBe). Company officials also expect to
reaffirm the outlook for medical membership for full year 2009, as discussed on
the Company's first quarter 2009 earnings conference call. A transcript of that
earnings call is available at
http://www.cigna.com/about_us/investor_relations/recent_disclosures.html.
Some of these meetings will be at the Sanford C. Bernstein & Co. Twenty-Fifth
Annual Strategic Decisions Conference, where CIGNA will make a presentation on
May 28, 2009 that is expected to begin at 10:00 a.m. Eastern Time. Investors,
analysts, and the general public are invited to listen to the presentation over
the Internet via webcast by visiting
http://www.cigna.com/about_us/investor_relations/index.html and going to the
Event Calendar.
Consolidated adjusted income from operations is consolidated income from continuing operations excluding realized investment results, special items and results of the Company's Guaranteed Minimum Income Benefits business, otherwise known as GMIB, which is reported in the Run-off Reinsurance segment.
In the 2009 earnings outlook discussed on the Company's first quarter 2009 earnings conference call, management assumed that VADBe would be approximately break-even for the remaining nine months of 2009. This assumption reflects management's view that the long-term reserve assumptions are appropriate and that equity market conditions and volatility are expected to return to more normal levels for the balance of the year. Investors are strongly encouraged to review the factors cited in the Cautionary Statement included in this report and the sensitivities discussed in the "Critical Accounting Estimates" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2008 for further details and information.
Information is not available for management (1) to reasonably estimate future realized investment gains (losses) or (2) to reasonably estimate future GMIB business results due in part to interest rate and stock market volatility and other internal and external factors; therefore it is not possible to provide a forward-looking reconciliation of adjusted income from operations to income from continuing operations. Potential losses related to the GMIB business, as well as investment impairments (both of which are sensitive to equity market and interest rate movements), could adversely impact the Company's consolidated results of operations and financial condition, and could reduce the capital of the Company's insurance subsidiaries as well as their dividend paying capabilities.
Additional special items for 2009 may include potential impacts associated with CIGNA's continuing cost reduction initiative and will include a one-time benefit of approximately $40 million, pre-tax, related to management's decision to freeze the CIGNA Pension Plan and CIGNA Supplemental Pension Plan effective July 1, 2009. Other than these items, information is not available for management to identify or reasonably estimate 2009 special items.
The foregoing statements represent management's current estimate of CIGNA's consolidated adjusted income from operations (excluding VADBe) and medical membership for full year 2009 as of the date of this report. Actual results may differ materially depending on a number of factors, and investors are urged to read the Cautionary Statement included in this report for a description of those
CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
The Company and its representatives may from time to time make written and oral forward-looking statements, including statements contained in press releases, in the Company's filings with the Securities and Exchange Commission, in its reports to shareholders and in meetings with analysts and investors. Forward-looking statements may contain information about financial prospects, economic conditions, trends and other uncertainties. These forward-looking statements are based on management's beliefs and assumptions and on information available to management at the time the statements are or were made. Forward-looking statements include but are not limited to the information concerning possible or assumed future business strategies, financing plans, competitive position, potential growth opportunities, potential operating performance improvements, trends and, in particular, the Company's productivity initiatives, litigation and other legal matters, operational improvement in the health care operations, and the outlook for the Company's full year 2009 results. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believe", "expect", "plan", "intend", "anticipate", "estimate", "predict", "potential", "may", "should" or similar expressions.
You should not place undue reliance on these forward-looking statements. The Company cautions that actual results could differ materially from those that management expects, depending on the outcome of certain factors. Some factors that could cause actual results to differ materially from the forward-looking statements include:
1. increased medical costs that are higher than anticipated in establishing
premium rates in the Company's health care operations, including increased
use and costs of medical services;
2. increased medical, administrative, technology or other costs resulting from
new legislative and regulatory requirements imposed on the Company's
employee benefits businesses;
3. challenges and risks associated with implementing operational improvement
initiatives and strategic actions in the ongoing business operations,
including those related to: (i) offering products that meet emerging market
needs, (ii) strengthening underwriting and pricing effectiveness, (iii)
strengthening medical cost and medical membership results, (iv) delivering
quality member and provider service using effective technology solutions,
(v) lowering administrative costs, and (vi) transitioning to an integrated
operating company model, including operating efficiencies related to the
transition;
4. risks associated with pending and potential state and federal class action
lawsuits, disputes regarding reinsurance arrangements, other litigation and
regulatory actions challenging the Company's businesses, government
investigations and proceedings, and tax audits;
5. heightened competition, particularly price competition, which could reduce
product margins and constrain growth in the Company's businesses, primarily
the health care business;
6. risks associated with the Company's mail order pharmacy business which,
among other things, includes any potential operational deficiencies or
service issues as well as loss or suspension of state pharmacy licenses;
7. significant changes in interest rates for a sustained period of time;
8. downgrades in the financial strength ratings of the Company's insurance
subsidiaries, which could, among other things, adversely affect new sales
and retention of current business;
9. limitations on the ability of the Company's insurance subsidiaries to
dividend capital to the parent company as a result of downgrades in the
subsidiaries' financial strength ratings, changes in statutory reserve or
capital requirements or other financial constraints;
10. inability of the program adopted by the Company to substantially reduce
equity market risks for
This list of important factors is not intended to be exhaustive. Other sections of the Company's most recent Annual Report on Form 10-K, including the "Risk Factors" section, our Form 10-Q for the quarter ended March 31, 2009 and other documents filed with the Securities and Exchange Commission include both expanded discussion of these factors and additional risk factors and uncertainties that could preclude
|
|